Chronic hepatitis B is a serious public health issue in China. The clinical management of hepatitis B is effective with the emergence of antiviral agents. The outcome of long-term therapy and nucleos(t)ide analogues stopping rules are currently unresolved issues and unmet needs. Thus, we need to pay more attention to clinical research to build large-sample and long-term follow-up cohorts and begin with the end in mind. We believe that the way to resolve the issues above will be found with the efforts of generations.
All Keywords
【저자키워드】 therapy, Clinical outcome, hepatitis B, Therapies, investigational,
【저자키워드】 therapy, Clinical outcome, hepatitis B, Therapies, investigational,